Number of Treatment Cycles Influences Development of Cytotoxic T Cells in Metastatic Breast Cancer Patients – A Phase I/II Study

By Wright Stephen E.   Rewers-Felkins Kathleen A.   Quinlin Imelda S.   Phillips Catherine A.   Townsend Mary   Philip Ramila   Zorsky Paul   Klug Panpit   Dai Lijun   Hussain Mohammad   Thomas Aabu A.   Sundaramurthy Chithraleka  

Immunological Investigations, Vol. 39, Iss. 6, 2010-01 ,pp. : 570-586

Informa Healthcare

Access to resources Recommend Favorite

Gene Expression Meta-Analysis of Potential Metastatic Breast Cancer Markers

By  

Current Molecular Medicine, Vol. 17, Iss. 3, 2017-10 ,pp. : 200-210

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer-associated retinopathy in patients with breast carcinoma

By Misiuk-Hojło Marta   Ejma Maria   Gorczyca Wojciech   Szymaniec Stanisław   Witkowska Danuta   Fortuna Wojciech   Międzybrodzki Ryszard   Rogozińska-Szczepka Jadwiga   Bartnik Wiesława  

Archivum Immunologiae et Therapiae Experimentalis, Vol. 55, Iss. 4, 2007-08 ,pp. : 261-265

Springer Publishing Company

Access to resources Recommend Favorite

The lived experience of breast cancer patients and couple distress

By Sprung Barbara R.   Janotha Brenda L.   Steckel Arleen J.  

Journal of the American Academy of Nurse Practitioners, Vol. 23, Iss. 11, 2011-11 ,pp. : 619-627

Blackwell Publishing

Access to resources Recommend Favorite

Metronomic chemotherapy for metastatic breast cancer to prolong time to treatment failure to 12 months or more

By Kontani  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 225-230

Spandidos Publications

Access to resources Recommend Favorite